Significance of Bio-intact PTH(1-84) assay in hemodialysis patients (Q45025729)

8 December 2017

title

Significance of Bio-intact PTH(1-84) assay in hemodialysis patients (English)

1 reference

8 December 2017

Masaaki Inaba

1

1 reference

8 December 2017

Senji Okuno

2

1 reference

8 December 2017

Yasuo Imanishi

3

1 reference

8 December 2017

Misako Ueda

4

1 reference

8 December 2017

Tomoyuki Yamakawa

5

1 reference

8 December 2017

Eiji Ishimura

6

1 reference

8 December 2017

Yoshiki Nishizawa

7

1 reference

8 December 2017

language of work or name

English

0 references

publication date

20 August 2004

1 reference

Osteoporosis International

8 December 2017

published in

1 reference

8 December 2017

volume

16

1 reference

8 December 2017

issue

5

1 reference

8 December 2017

page(s)

517-525

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-004-1715-1

8 December 2017

exact match

0 references

cites work

Hyperparathyroidism is augmented by ovariectomy in Nagase analbuminemic rats

1 reference

12 December 2020

PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease

1 reference

12 December 2020

Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism

1 reference

12 December 2020

Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone

1 reference

12 December 2020

A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure

1 reference

12 December 2020

Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure

1 reference

12 December 2020

Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays

1 reference

12 December 2020

Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.

1 reference

12 December 2020

Increasing body fat mass in the first year of hemodialysis

1 reference

12 December 2020

Effects of Plasma Calcium Concentration on the Relative Proportion of Hormone and Carboxyl Fragments in Parathyroid Venous Blood*

1 reference

12 December 2020

Parathyroid hormone: regulation of synthesis and secretion

1 reference

12 December 2020

Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia

1 reference

12 December 2020

Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis

1 reference

12 December 2020

Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides

1 reference

12 December 2020

Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes

1 reference

12 December 2020

Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum

1 reference

12 December 2020

Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values

1 reference

12 December 2020

Serum pyridinolines as specific markers of bone resorption in hemodialyzed patients

1 reference

12 December 2020

Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays

1 reference

12 December 2020

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

1 reference

12 December 2020

Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation

1 reference

12 December 2020

Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor

1 reference

12 December 2020

Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline

1 reference

12 December 2020

Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay

1 reference

12 December 2020

Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function

1 reference

12 December 2020

Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor

1 reference

12 December 2020

A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples

1 reference

12 December 2020

1 reference

12 December 2020

Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients

1 reference

12 December 2020

A novel mechanism for skeletal resistance in uremia

1 reference

12 December 2020

Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus

1 reference

12 December 2020

Metabolism of parathyroid hormone: physiologic and clinical significance

1 reference

12 December 2020

Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism

1 reference

12 December 2020

10.1007/S00198-004-1715-1

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1036773610

0 references

1 reference